Loading clinical trials...

Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy | Clinical Trials | Clareo Health

Back to clinical trial search

Enrolling By InvitationNCT03610906

Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy

New data suggests that the current treatment for pediatric adamantinomatous craniopharyngioma (CPA) may not be as effective as it could be.

Lead sponsor: University of Colorado, Denver•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 2

Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults

NCT05465174 · Craniopharyngioma, Child, Craniopharyngioma, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 23, 2026Terms

Trial snapshot

StatusENROLLING_BY_INVITATION

Phase—

Enrollment250

Start dateMar 2019

Last updatedMar 23, 2026

Condition

Craniopharyngioma, Child

Locations shown

Children's Hospital Colorado

Aurora, Colorado

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 23, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions